Revvity to Acquire ACD/Labs to Strengthen Scientific Software Portfolio
Revvity, Inc. has entered into a definitive agreement to acquire ACD/Labs, a global provider of scientific software that supports analytical characterization and molecular design for pharmaceutical and material sciences.
Revvity To Acquire ACD/Labs | 25/11/2025 | By Darshana | 191
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy